Sid Taubenfeld

CEO - TO Pharma
 http://tikunolamusa.com/

Sid Taubenfeld is the CEO of TO Pharma, the Medical and Research division of Tikun Olam USA. Mr. Taubenfeld started his career as a clinical pharmacist at Bellevue Hospital before becoming buyside healthcare equities research analyst and portfolio manager. He has worked at Balyasny Asset Management (BAM), RH Capital, Scopia Capital, PAW Partners and Celsion Corporation. Mr. Taubenfeld received his degree from the Brooklyn College of Pharmacy.

Social Profiles

All Sessions by Sid Taubenfeld

  • Day 3 - The Opioid Epidemic, Data, Technology, Research, and Northeast U.S. Market Updates

    May 2, 2018

  • 10:00 AM  - 10:50 AM
    With international markets such as Israel and Canada having lower barriers to research opportunities than the United States, CannabisLearn will bring experts from around the world to discuss the current status of international research. Join thought leaders from Israel, Canada, Jamaica, and other international markets to learn how research is shaping the economic realities of a global marketplace. Insight from clinical studies, future research opportunities within the USA and globally, and barriers to high-quality data will be topics covered during this session. If you are working with, or caring for, medical cannabis patients this is not a panel you will want to miss.
    Market Trends
    Medical
    Regulatory
    Research
    Where
    204 B




Share

Sid Taubenfeld